Goldman Sachs’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43M | Buy |
|
|||||
|
2025
Q1 | $26.9M | Sell |
|
|||||
|
2024
Q4 | $29.3M | Sell |
|
|||||
|
2024
Q3 | $37M | Buy |
|
|||||
|
2024
Q2 | $20.5M | Buy |
|
|||||
|
2024
Q1 | $15.2M | Buy |
|
|||||
|
2023
Q4 | $11.8M | Buy |
|
|||||
|
2023
Q3 | $7.79M | Sell |
|
|||||
|
2023
Q2 | $15.4M | Buy |
|
|||||
|
2023
Q1 | $10.6M | Sell |
|
|||||
|
2022
Q4 | $6.73M | Sell |
|
|||||
|
2022
Q3 | $6.38M | Buy |
|
|||||
|
2022
Q2 | $5M | Buy |
|
|||||
|
2022
Q1 | $8.2M | Buy |
|
|||||
|
2021
Q4 | $4.23M | Sell |
|
|||||
|
2021
Q3 | $7.5M | Buy |
|
|||||
|
2021
Q2 | $17.6M | Sell |
|
|||||
|
2021
Q1 | $10.7M | Sell |
|
|||||
|
2020
Q4 | $11.1M | Buy |
|
|||||
|
2020
Q3 | $4.34M | Sell |
|
|||||
|
2020
Q2 | $9.36M | Buy |
|
|||||
|
2020
Q1 | $449K | Buy |
|
|||||
|
2019
Q4 | $142K | Sell |
|
|||||
|
2019
Q3 | $1.89M | Buy |
|
|||||
|
2019
Q2 | $291K | Sell |
|
|||||
|
2019
Q1 | $1.27M | Buy |
|
|||||
|
2018
Q4 | $188K | Sell |
|
|||||
|
2018
Q3 | $405K | Sell |
|
|||||
|
2018
Q2 | $557K | Buy |
|
|||||
|
2018
Q1 | $267K | Buy |
|
|||||
|
2017
Q4 | $615K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $282K | Buy |
|